Published in J Bone Miner Res on December 01, 1999
Osteoporosis in men. Endocr Rev (2008) 1.80
Serum 25-hydroxyvitamin D levels and rate of hip bone loss in older men. J Clin Endocrinol Metab (2009) 1.44
Insulin-like growth factor-binding protein-5 induces a gender-related decrease in bone mineral density in transgenic mice. Endocrinology (2004) 1.19
Female reproductive system and bone. Arch Biochem Biophys (2010) 1.19
Bone and skeletal muscle: neighbors with close ties. J Bone Miner Res (2013) 1.19
Endogenous anabolic hormones and hypermetabolism: effect of trauma and gender differences. Ann Surg (2005) 1.18
Physiology of bone loss. Radiol Clin North Am (2010) 1.09
Aging and bone loss: new insights for the clinician. Ther Adv Musculoskelet Dis (2012) 1.02
The multi-functional role of insulin-like growth factor binding proteins in bone. Pediatr Nephrol (2004) 1.01
Serum levels of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-1 to -6 and their relationship to bone metabolism in osteoporosis patients. Eur J Intern Med (2003) 0.94
Male osteoporosis. Endocrinol Metab Clin North Am (2012) 0.92
Function of matrix IGF-1 in coupling bone resorption and formation. J Mol Med (Berl) (2013) 0.90
Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis. Int J Endocrinol (2014) 0.89
Mapping quantitative trait loci that influence serum insulin-like growth factor binding protein-5 levels in F2 mice (MRL/MpJ X SJL/J). Endocrinology (2003) 0.88
Low levels of plasma IGF-1 inhibit intracortical bone remodeling during aging. Age (Dordr) (2012) 0.79
Telomerase activity promotes osteoblast differentiation by modulating IGF-signaling pathway. Biogerontology (2015) 0.78
Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer. Br J Cancer (2001) 0.78
Interaction between bone and muscle in older persons with mobility limitations. Curr Pharm Des (2014) 0.77
The hormonal profile of hip fracture female patients differs from community-dwelling peers over a 1-year follow-up period. Osteoporos Int (2010) 0.77
The use of anabolic agents in catabolic states. J Burns Wounds (2007) 0.76
Skeletal effects of growth hormone and insulin-like growth factor-I therapy. Mol Cell Endocrinol (2015) 0.76
Differences in exposure to stimulatory and inhibitory components of the insulin-like growth factor (IGF) system in patients with femoral neck versus trochanteric fracture. Age Ageing (2005) 0.75
Osteoporosis biomarkers act as predictors for diagnosis of chronic renal insufficiency in elder patients. Int J Clin Exp Med (2015) 0.75
The Unexplored Crossroads of the Female Athlete Triad and Iron Deficiency: A Narrative Review. Sports Med (2017) 0.75
Intensive insulin therapy in critically ill patients. N Engl J Med (2001) 40.00
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med (1995) 10.99
An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods (2001) 6.68
Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res (1999) 6.39
Genetic variability in adult bone density among inbred strains of mice. Bone (1996) 3.66
Vitamin D and diabetes. Diabetologia (2005) 3.58
Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16
Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration. J Clin Invest (1981) 3.15
Synthesis, Fourier transform infrared and Raman spectra, assignments and analysis of N-(phenyl)- and N-(chloro substituted phenyl)-2,2-dichloroacetamides. Spectrochim Acta A Mol Biomol Spectrosc (2004) 3.04
Quantitative trait loci for femoral and lumbar vertebral bone mineral density in C57BL/6J and C3H/HeJ inbred strains of mice. J Bone Miner Res (2001) 2.94
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69
Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax (2003) 2.68
Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med (1990) 2.67
Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev (1997) 2.63
Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc Natl Acad Sci U S A (2001) 2.42
The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech (2003) 2.30
Camptodactyly in a painting by Dirk Bouts (c. 1410-1475). J R Soc Med (2004) 2.28
Interspecies differences in bone composition, density, and quality: potential implications for in vivo bone research. Endocrinology (1998) 2.24
Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography. Bone (1998) 2.18
Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. J Clin Endocrinol Metab (1998) 2.17
The relationship between osteoporosis and osteoarthritis. Clin Rheum Dis (1985) 2.14
Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. Ann Rheum Dis (1986) 2.13
Renal function, cytogenetic measurements, and sexual development in adolescents in relation to environmental pollutants: a feasibility study of biomarkers. Lancet (2001) 2.13
Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities. Bone (1997) 2.09
Arthritis in Flemish paintings (1400-1700). Br Med J (1977) 2.03
Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment. Br J Rheumatol (1998) 2.02
IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J Endocrinol (2002) 2.01
Incorporation of sodium fluoride into cortical bone does not impair the mechanical properties of the appendicular skeleton in rats. Calcif Tissue Int (1992) 1.95
Cloning and analysis of ermG, a new macrolide-lincosamide-streptogramin B resistance element from Bacillus sphaericus. J Bacteriol (1987) 1.94
Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc Natl Acad Sci U S A (2000) 1.90
A simple method for enriching populations of transfected CHO cells for cells of higher specific productivity. J Immunol Methods (2003) 1.87
Thyroid function in patients with hyperemesis gravidarum. Am J Obstet Gynecol (1982) 1.87
Bone mass in osteoarthrosis, measured in vivo by photon absorption. J Bone Joint Surg Am (1974) 1.85
How Renoir coped with rheumatoid arthritis. BMJ (1998) 1.84
Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology (1997) 1.84
Vitamin D-binding protein (Gc-globulin) binds actin. J Biol Chem (1980) 1.80
Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. J Bone Miner Res (1995) 1.79
Late-onset hypogonadism and mortality in aging men. J Clin Endocrinol Metab (2013) 1.77
Glucocorticoid-induced osteoporosis. N Engl J Med (1983) 1.74
The measurement of the vitamin D-binding protein in human serum. J Clin Endocrinol Metab (1977) 1.73
UDP-N-acetylglucosamine acyltransferase of Escherichia coli. The first step of endotoxin biosynthesis is thermodynamically unfavorable. J Biol Chem (1993) 1.72
Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women. J Clin Endocrinol Metab (2001) 1.70
Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia (1994) 1.68
Quantitative trait loci for bone density in C57BL/6J and CAST/EiJ inbred mice. Mamm Genome (1999) 1.68
Nucleotide sequence, organisation and structural analysis of the products of genes in the nirB-cysG region of the Escherichia coli K-12 chromosome. Eur J Biochem (1990) 1.66
Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. Endocrinology (1998) 1.66
Age-related decreases in insulin-like growth factor-I and transforming growth factor-beta in femoral cortical bone from both men and women: implications for bone loss with aging. J Clin Endocrinol Metab (1994) 1.63
Rheumatoid lymphedema. J Rheumatol (1987) 1.62
Diabetes mellitus and female sexuality: a review of 25 years' research. Diabet Med (1998) 1.62
Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. Gastroenterology (1992) 1.62
Assessment of the strength of proximal femur in vitro: relationship to femoral bone mineral density and femoral geometry. Bone (1997) 1.62
Effect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total bone mineral mass. Metabolism (1977) 1.61
Regulation of serum 1alpha,25-dihydroxyvitamin D3 by calcium and phosphate in the rat. Science (1975) 1.60
Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporos Int (1999) 1.59
Chronic widespread pain is associated with slower cognitive processing speed in middle-aged and older European men. Pain (2010) 1.58
Does hip strength analysis explain the lower incidence of hip fracture in the People's Republic of China? Bone (2004) 1.57
Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2002) 1.56
Growth factors for bone growth and repair: IGF, TGF beta and BMP. Bone (1996) 1.53
Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy. Kidney Int (2000) 1.52
Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects. Osteoporos Int (1995) 1.51
The European Spine Phantom--a tool for standardization and quality control in spinal bone mineral measurements by DXA and QCT. Eur J Radiol (1995) 1.51
Quantification of skeletal alkaline phosphatase in osteoporotic serum by wheat germ agglutinin precipitation, heat inactivation, and a two-site immunoradiometric assay. Clin Chem (1994) 1.50
Methotrexate osteopathy, does it exist? J Rheumatol (1996) 1.50
Phosphotyrosyl protein phosphatases. Biochem J (1989) 1.49
Osteoporosis and osteoarthritis (osteoarthrosis). Anthropometric distinctions. JAMA (1983) 1.47
INFORMAS (International Network for Food and Obesity/non-communicable diseases Research, Monitoring and Action Support): overview and key principles. Obes Rev (2013) 1.46
The variable incidence of hip fracture in southern Europe: the MEDOS Study. Osteoporos Int (1994) 1.46
Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2003) 1.45
The accuracy of peripheral skeletal assessment at the radius in estimating femoral bone density as measured by dual-energy X-ray absorptiometry: a comparative study of single-photon absorptiometry and computed tomography. J Intern Med (1997) 1.44
Occult ectopic ACTH secretion due to recurrent lung carcinoid: long-term control of hypercortisolism by continuous subcutaneous infusion of octreotide. Clin Endocrinol (Oxf) (1998) 1.43
Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Possible mechanism of increased bone density and protection against osteoporosis. Arthritis Rheum (1993) 1.42
The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Cancer Res (1999) 1.42
Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism (1984) 1.41
FTIR and FTRaman spectra, assignments, ab initio HF and DFT analysis of 4-nitrotoluene. Spectrochim Acta A Mol Biomol Spectrosc (2010) 1.41
Prevention and treatment of glucocorticoid-induced osteoporosis. A pathogenetic perspective. Chest (1992) 1.40
Deficiency of the growth hormone-insulin-like growth factor-I axis potentially involved in age-related alterations in body composition. Gerontology (1996) 1.39
Bone growth factors. Clin Orthop Relat Res (1991) 1.39
Attenuation of posttraumatic muscle catabolism and osteopenia by long-term growth hormone therapy. Ann Surg (2001) 1.38
Total lymphoid irradiation in rheumatoid arthritis. A ten-year followup. Arthritis Rheum (1997) 1.38
Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones. J Clin Endocrinol Metab (1997) 1.38
Exercise and mechanical loading increase periosteal bone formation and whole bone strength in C57BL/6J mice but not in C3H/Hej mice. Calcif Tissue Int (2000) 1.36
Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene. Eur J Hum Genet (1999) 1.36
Identification of transcription activators that regulate gonococcal adaptation from aerobic to anaerobic or oxygen-limited growth. Mol Microbiol (2000) 1.36
A systematic survey of HLA-A,B,C and D antigens and drug toxicity in rheumatoid arthritis. J Rheumatol (1984) 1.36
Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab (2005) 1.35
Diabetic bone disease. Calcif Tissue Int (1991) 1.35